Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01639235 · ClinicalTrials.gov registry record
Effects of Secondhand Smoke on Flight Attendant Health
A clinical trial of Cardiopulmonary Disease, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 592
- Enrollment target
- 1
- Study location
NCT01639235: Completed study of Cardiopulmonary Disease, sponsored by University of California, San Francisco.
NCT01639235 is a study of Cardiopulmonary Disease that has completed, run by University of California, San Francisco. The registered enrollment target is 592 participants, above the 386-participant average among 4 other Cardiopulmonary Disease trials with a reported enrollment target (53% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01639235, a study of Cardiopulmonary Disease, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 592 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study on a population of flight attendants who were exposed to occupational secondhand tobacco smoke (SHS). This research will examine associations between flight attendant SHS exposure and development of respiratory illnesses, reproductive problems, and cardiovascular diseases.
Primary Outcome
A spirometry test is performed by the Clinical Research Coordinator to establish the lung function of the flight attendant participant and medical assistants from the cardiovascular care clinic administer a 12-lead non-invasive electrocardiogram.
Conditions Studied
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2005-01-31 |
| Est. Completion | 2020-12-31 |
What the finished NCT01639235 record still lists
NCT01639235 is an observational study that tracks outcomes without assigning an intervention. The registered 592 participants enrollment target is mid-sized for trials with a published cap, above the 386-participant average among 4 other Cardiopulmonary Disease trials with a reported enrollment target (53% higher).
The record links to 1 condition, with Cardiopulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01639235 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01639235 about?
NCT01639235 is a clinical study titled "Effects of Secondhand Smoke on Flight Attendant Health". This is a study on a population of flight attendants who were exposed to occupational secondhand tobacco smoke (SHS). This research will examine associations between flight attendant SHS exposure and development of respiratory illnesses, reproductive problems, and cardiovascular diseases.
What is the current status of trial NCT01639235?
This trial is currently completed. The enrollment target is 592 participants. The study started on 2005-01-31. Estimated completion is 2020-12-31.
What conditions does trial NCT01639235 study?
This clinical trial studies the following conditions: Cardiopulmonary Disease.
Who is sponsoring clinical trial NCT01639235?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01639235 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
RECRUITING · Phase 2
-
World Trade Center (WTC) CHEST
COMPLETED
-
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
COMPLETED
-
Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04701684 · 594 participants · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI